Ujian genetik baru untuk barah kanak-kanak

Ujian genetik baru untuk barah kanak-kanak
Ujian genetik baru untuk kanser kanak-kanak, 81 ujian genetik berbeza untuk kanser kanak-kanak. Ujian genetik untuk kanser kanak-kanak di India. Kos ujian genetik pada kanser kanak-kanak.

Kongsi Post ini

Para saintis British memulakan ujian genetik tumor kanak-kanak. Para saintis British berharap bahawa ujian genetik akan memberikan pesakit yang lebih muda rawatan yang lebih baru dan lebih diperibadikan yang akan meningkatkan kelangsungan hidup mereka. Ujian baru menganalisis 81 perubahan genetik kanser yang berbeza.

Scientists say the test will lead to “a higher level of playing field” and accelerate children’s access to important new drug treatments. The test was performed at the Royal Marsden National Health System Hospital in London and will be tested on 400 children from all over the UK over the next two years.

The test has been implemented with genetic funding from the National Institutes of Health (NIHR) foundation and the Kanser Institute. A charity called Christopher has provided more than £ 300,000 in funding to develop the test. The organization was founded by a couple whose children died of invasive tumor otak at the age of six.

This is a real first step towards personalized rawatan kanser for children,” said Christopher’s parents, Karen and Kevin Capel. Christopher got a generic tumor. Hopefully, in the future, children will know exactly what type of tumor they have.” “We almost feel that the treatment for the child is not to kill the cancer, but to kill our child.”
“He used to be a healthy, happy, very athletic 4-year-old kid. But he became unable to speak or even eat on his own, and lost weight. “In the year he was diagnosed, he was unable to grow into a child of his age. We tried to keep him from other children.”

Tumor ganas sangat jarang berlaku pada kanak-kanak, tidak banyak populasi pesakit, dan ujian klinikal for pharmaceutical companies will lack motivation. This means that children will miss the opportunity to receive targeted treatments for cancer cells without damaging healthy cells with innovative therapies.

Professor Louis Chesler, who is leading the genetic testing research, said: “Children often don’t have equal access to the most advanced and potentially beneficial cancer treatments.” “The cost of developing gene-targeted drugs is very high. They tend to Test it on adults first so that more people can get treatment and the results can be seen faster. ”
“This test is an incredible advance because it will very clearly identify all genetic changes in the tumor.” “Gene testing gives clinicians an extremely powerful tool—helping them choose the right medicine for their children and do their best. It may be possible to quickly determine the effectiveness of these drugs. ”

Children’s tumors are usually genetically simpler than adult tumors, so eventually these drugs may be more effective in children.” The goal of ujian genetik is to give scientists and doctors detailed genes for childhood tumors within a few weeks of diagnosis. information.

Genetic testing gives doctors strong evidence to use terapi yang disasarkan for younger patients, potentially preventing these patients from experiencing the side effects associated with traditional chemotherapy and radiation therapy.

Jack Daly, 14, from Wokingham, was diagnosed with a brain tumor when he was 7 and is now a brain tumor terselamat. Radiotherapy helped save his life, but left him with sequelae. “My athletic ability is not very good,” Jack said. “I have to get someone to help me dress and undress at school.” “My balance is not good-I am awkward and often fall. I worked hard at school, where I found friendship.” Jack and his mother, Helen, use their donations to make ends meet in Capels-hoping that ujian genetik will make a huge difference in the quality of life of future children.

"Orang tidak benar-benar melihat masalahnya kerana Jack telah pulih dari barah. Dia tidak perlu berada di kerusi roda. Dia tidak perlu memakai pembalut, ”kata Helen.
"Sekiranya anda pernah melihat Jack, dia kelihatan seperti remaja lelaki yang normal. Tetapi apa yang anda tidak nampak adalah kerosakan tisu otak yang disebabkan oleh rawatan. "

URL sumber artikel ini: http://www.bbc.com/news/health-35918744

Langgani Buletin Kami

Dapatkan kemas kini dan jangan terlepas blog daripada Cancerfax

Lebih Banyak untuk diterokai

Terapi Sel T CAR Berasaskan Manusia: Kejayaan Dan Cabaran
Terapi T-Cell CAR

Terapi Sel T CAR Berasaskan Manusia: Kejayaan dan Cabaran

Terapi sel T CAR berasaskan manusia merevolusikan rawatan kanser dengan mengubah suai genetik sel imun pesakit sendiri untuk menyasar dan memusnahkan sel kanser. Dengan memanfaatkan kuasa sistem imun badan, terapi ini menawarkan rawatan yang mujarab dan diperibadikan dengan potensi untuk pengampunan berpanjangan dalam pelbagai jenis kanser.

Memahami Sindrom Pembebasan Sitokin: Punca, Gejala dan Rawatan
Terapi T-Cell CAR

Memahami Sindrom Pembebasan Sitokin: Punca, Gejala dan Rawatan

Sindrom Pembebasan Sitokin (CRS) ialah tindak balas sistem imun yang sering dicetuskan oleh rawatan tertentu seperti imunoterapi atau terapi sel CAR-T. Ia melibatkan pelepasan sitokin yang berlebihan, menyebabkan simptom daripada demam dan keletihan kepada komplikasi yang boleh mengancam nyawa seperti kerosakan organ. Pengurusan memerlukan pemantauan yang teliti dan strategi intervensi.

Perlukan bantuan? Pasukan kami sedia membantu anda.

Kami menginginkan pemulihan yang cepat dari yang tersayang dan yang terdekat.

Mula berbual
Kami Dalam Talian! Sembang Dengan Kami!
Imbas kodnya
helo,

Selamat datang ke CancerFax !

CancerFax ialah platform perintis khusus untuk menghubungkan individu yang menghadapi kanser peringkat lanjut dengan terapi sel terobosan seperti terapi CAR T-Cell, terapi TIL dan ujian klinikal di seluruh dunia.

Beritahu kami apa yang boleh kami lakukan untuk anda.

1) Rawatan kanser di luar negara?
2) Terapi T-Cell CAR
3) Vaksin kanser
4) Perundingan video dalam talian
5) Terapi proton